Vaxcyte’s $690 Million Public Offering

Cooley advised Vaxcyte, while Latham & Watkins represented the underwriters on the offering. Vaxcyte, a clinical-stage vaccine innovation company, announced its underwritten public offering of common stock and...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

MasTec’s Notes Exchange Offer

Simpson Thacher represented the dealer managers, J.P. Morgan Securities LLC and BofA Securities, Inc., in the transaction. The transaction consisted in an exchange of a portion...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here